CIK 0001907108 · <br>Emerging growth company
Lexeo Therapeutics, Inc.
Sign in to watch- Ticker
- LXEO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 854012572
- Phone
- (212) 547-9879
- Business address
- 345 PARK AVENUE SOUTH, FLOOR 6, NEW YORK, NY, 10010
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $43,228
- in 3 filings
Net −$43,228. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-15 | Adler Eric Chief Medical Officer | Grant or award | +9,570 | 76,643 | ||
| 2025-09-12 | Townsend Richard Nolan Chief Executive Officer | Grant or award | +2,193 | $2.64 | $6K | 222,251 |
| 2025-08-29 | Tamayo Louis Edward Chief Financial Officer | Grant or award | +45,000 | 45,000 | ||
| 2025-08-29 | Tamayo Louis Edward Chief Financial Officer | Grant or award · Stock Option (right to buy) | +280,000 | 280,000 | ||
| 2025-08-18 | Otero Jose Manuel Chief Technical Officer | Sale | −721 | $9.27 | $7K | 63,476 |
| 2025-08-18 | Townsend Richard Nolan Chief Executive Officer | Sale | −1,115 | $4.67 | $5K | 220,058 |
| 2025-08-18 | Otero Jose Manuel Chief Technical Officer | Sale | −2,848 | $4.67 | $13K | 60,372 |
| 2025-08-18 | Robertson Jenny Chief Legal Officer | Sale | −542 | $4.67 | $3K | 62,556 |
| 2025-08-18 | Adler Eric Chief Medical Officer | Sale | −608 | $4.67 | $3K | 67,073 |
| 2025-08-18 | Townsend Richard Nolan Chief Executive Officer | Sale | −2,735 | $4.67 | $13K | 220,058 |
| 2025-08-18 | See Tai Sandi Chief Development Officer | Sale | −382 | $4.67 | $2K | 58,860 |
| 2025-06-26 | Tanguler Tolga Director | Grant or award · Stock Option (right to buy) | +14,583 | 14,583 | ||
| 2025-06-26 | Van Hauwermeiren Timothy Director | Grant or award · Stock Option (right to buy) | +22,916 | 22,916 | ||
| 2025-06-26 | DIAZ REINALDO M Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2025-06-26 | COOPERSTONE BRENDA Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2025-06-26 | CHOLMONDELEY PAULA H Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2025-06-26 | Altschuler Steven Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2025-06-26 | Agger Mette Kirstine Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2025-05-16 | Townsend Richard Nolan Chief Executive Officer | Sale | −1,074 | $2.77 | $3K | 221,173 |
| 2025-05-16 | Adler Eric Chief Medical Officer | Sale | −585 | $2.77 | $2K | 67,681 |
Page 4 of 9 · 165 trades